The Technical Analyst
Select Language :
Mereo BioPharma Group plc [MREO]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Mereo BioPharma Group plc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Mereo BioPharma Group plc is listed at the  Exchange

-0.64% $3.09

America/New_York / 18 mar 2024 @ 16:00


Mereo BioPharma Group plc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 396.74 mill
EPS: -0.320
P/E: -9.66
Earnings Date: Mar 25, 2024
SharesOutstanding: 128.39 mill
Avg Daily Volume: 1.754 mill
RATING 2024-03-18
B-
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Neutral
P/E: Sell
Price To Book: Buy
QUARTER GROWTHS
4/212/223/224/221/232/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/an/an/an/a
Ebitn/an/an/an/an/an/a
Asset n/an/an/an/a
Debtn/an/an/an/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -9.66 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-1.64x
Company: PE -9.66 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$0.457
(-85.20%) $-2.63
Date: 2024-03-18
Expected Trading Range (DAY)

$ 2.81 - 3.37

( +/- 9.16%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-08 Ekblom Anders Buy 45 000 Share Options (Right to buy)
2024-02-08 Ekblom Anders Buy 19 471 Deferred Restricted Stock Units
2024-02-08 Jacquet Pierre Buy 45 000 Share Options (Right to buy)
2024-02-08 Jacquet Pierre Buy 15 553 Deferred Restricted Stock Units
2024-02-08 Yoskowitz Marc J Buy 45 000 Share Options (Right to buy)
INSIDER POWER
-60.72
Last 97 transactions
Buy: 2 158 393 | Sell: 9 188 547

Forecast: 16:00 - $3.10

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $3.10
Forecast 2: 16:00 - $3.10
Forecast 3: 16:00 - $3.10
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $3.09 (-0.64% )
Volume 0.823 mill
Avg. Vol. 1.754 mill
% of Avg. Vol 46.92 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Mereo BioPharma Group plc

Last 12 Months

Last 12 months chart data with high, low, open and close for Mereo BioPharma Group plc

RSI

Intraday RSI14 chart for Mereo BioPharma Group plc

Last 10 Buy & Sell Signals For MREO

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$4.01N/AActive
Profile picture for
            Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor. The company is also developing Navicixizumab (OMP-305B83), which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Acumapimod (BCT-197), a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole (BGS-649), an oral aromatase inhibitor for the treatment of hypogonadotropic hypogonadism. In addition, it develops rare disease product candidates, including Setrusumab (BPS-804), a novel antibody for the treatment of osteogenesis imperfecta; and Alvelestat (MPH-966), an oral small molecule that is in Phase II clinical trial to treat Alpha-1 antitrypsin deficiency. The company has a collaboration with The University of Texas MD Anderson Cancer Center to evaluate anti-TIGIT therapeutic antibody candidate, etigilimab. Mereo BioPharma Group plc was incorporated in 2015 and is based in London, the United Kingdom.

Last 10 Buy Signals

Date Signal @
AMKTUSDMar 18 - 22:21210.02
CREAMUSDMar 18 - 22:1726.42
^AXMJMar 18 - 21:3617 386
^AXEJMar 18 - 21:3610 376
TETUSDMar 18 - 21:4733.90
USDCUSDMar 18 - 21:46$0.998
HBTCUSDMar 18 - 21:3917 810
000001.SSMar 18 - 21:30PTS3 075.15
^AXUJMar 18 - 21:238 283.40
RETHUSDMar 18 - 21:393 648.22

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.